The TIN CUP for CMT
Charcot-Marie-Tooth disease, known as CMT, affects 1 in 2500 people which is more than 2.8 million worldwide. This debilitating, medically incurable disease attacks the peripheral nerves and slowly cripples those affected. Symptoms include muscle atrophy in the legs and arms, foot drop leading to frequent tripping and falling, fatigue and slow progression of function loss in the hands and feet.
TIN, established in 2017, has assembled a highly skilled and diverse board of directors and brought together an advisory board comprised of top CMT researchers and physical therapists. TIN has funded several key projects including one working toward designing and testing a therapeutic antibody and another involved in defining specifics related to the effects of exercise on CMT patient health. TIN has also developed and published a series of educational physical therapy videos to help those with CMT remain as physically able as we work to find a cure.
There is no known pharmaceutical treatment for CMT and we, the patient population, need your help. We invite you to join us in our mission of finding and funding projects with true promise of providing successful therapies and treatment strategies for CMT patients.
